BSH 2019 | Defining the group of MCL patients who do well without treatment

Simon Rule

Simon Rule, MD, Plymouth University, Plymouth, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses the watch-and-wait strategy in mantle cell lymphoma (MCL), and research being done to help define the group of patients who can do well without treatment.

Share this video